About Us
Our Values
At Symmetry Biosciences, our values define who we are and guide everything we do.
We are committed to:
- Innovation: We constantly push the boundaries of science and technology, seeking novel solutions that advance drug delivery and GMP services.
- Integrity: Honesty, transparency, and ethical practices are at the core of our operations. We are committed to maintaining the highest standards in all our interactions—whether with clients, partners, or within our team—to build trust and credibility.
- Sustainability: We are dedicated to sustainable practices, ensuring that our processes and technologies minimize environmental impact. Our focus on green chemistry and sustainable development underpins our approach to drug delivery technology.
- Collaboration: We believe that the best outcomes are achieved when we work together. We foster a culture of teamwork, both within our organization and with our external partners, to combine expertise, share knowledge, and drive success.
Our values shape a collaborative, innovative, and ethical culture where every team member is empowered to make a difference.
Partnerships and Collaborations
Symmetry Biosciences thrives through partnerships with universities, research institutions, and industry leaders.
Our collaborations play a vital role in our progress and commitment to innovation:
Academic Collaborations: We are actively partnering with esteemed institutions, such as North Carolina State University and the University of Minnesota, to advance research in drug delivery systems. These partnerships provide a foundation for groundbreaking research, development of new technologies, and access to leading expertise.
Industry Partnerships: Symmetry Biosciences collaborates with industry leaders to enhance our capabilities and expand our reach. These partnerships enable us to bring our technologies to market faster and offer advanced solutions to our clients.
Evolving Collaborations: We are continuously building new relationships and evolving existing ones to stay at the forefront of the biotech industry. By connecting with like-minded organizations, we aim to enhance our expertise and create value for our clients and the broader scientific community.
Board Members
Our leadership Team with decades of combined industry experience.
Dr. Harold Meckler
Dr. Harold Meckler, Ph.D. is a highly accomplished OrganicProcess Chemist with over four decades of experience in the pharmaceutical industry. His expertise lies in inventing and scaling up chemical processes essential for pharmaceutical manufacturing. Throughout his career, Dr. Meckler has nurtured numerous chemists, many of whom have excelled in leadership roles within pharmaceutical and chemical sectors.
Since 2013, Dr. Meckler has served as President and CSO of Chemapotheca, a firm specializing in Technology Development and Consulting Services across pharmaceuticals, cosmetics, agrochemicals, and other industries. Under his stewardship, Chemapotheca has acquired substantial intellectual property focusing notably on ADHD treatments. Prior to his tenure at Chemapotheca, Dr. Meckler held senior positions at AMRI from 1995 to 2013. During his tenure, he oversaw Chemical Development and cGMP Production, significantly expanding AMRI's global presence and capabilities Dr. Meckler earned his Ph.D. from the State University of New York at Buffalo in 1983, with a specialization in Nitrone Cycloaddition Chemistry. He has authored numerous peer-reviewed publications and holds over 20 US Patents. Dr. Meckler's dedication to advancing pharmaceutical science and innovation continues to drive his impactful contributions to the industry.
Karl F. Popp
Karl F. Popp, R. Ph. is a seasoned consultant and licensed pharmacist who founded KPopp Consulting, LLC in 2010, providing advisory services to pharmaceutical, cosmetic, and allied industries. With a background spanning over 50 years in the industry, Karl previously served as Director of Product Development and Senior Director of Special Projects at Stiefel Laboratories, where he oversaw global research, external manufacturing, and managed intellectual property. As Vice President of Pharmapotheca A, LLC, Karl focuses on developing and commercializing pharmaceutical technologies for ADHD treatment. He holds a B.S. in Pharmacy from Albany College of Pharmacy and an M.B.A. from Rensselaer Polytechnic Institute, and is licensed to practice pharmacy in New York. Karl has contributed significantly to his field with over 30 patents, technical articles, and book chapters, and is recognized as a Fellow of the U.S. Society of Cosmetic Chemists. Beyond his professional achievements, Karl is actively involved in community and support groups such as the American Cancer Society and Bladder Cancer Awareness Network, reflecting his commitment to making a difference both in and out of the industry.
Why Choose Symmetry Biosciences?
- State-of-the-Art Facilities: Our GMP lab is equipped with the latest technology, ensuring the highest standards of precision and reliability in every process.
- Expert Team: Our highly trained scientists and technicians bring extensive experience and expertise to each project, guaranteeing excellence at every stage.
- Proven Quality: With a robust quality management system, we ensure comprehensive documentation, regular audits, and continuous staff training to uphold the highest standards of quality.